October 23, 2014 12:45 AM ET


Company Overview of EleGene AG

Company Overview

EleGene AG went out of business. EleGene AG is a biotech company based in Martinsried, Germany. Its core competence lies in the identification and validation of new drug targets in order to determine the basis for the development of new therapeutic drugs, especially for the treatment of neurological disorders. It employs cutting-edge technology in the field of molecular genetics. The company uses the increasing amount of information available concerning the interaction of homologous genes in evolutionary conserved pathways.

Am Klopferspitz 19

Martinsried,  82152


Founded in 1999


49 89 700 7650


49 89 700 76522

Key Executives for EleGene AG

EleGene AG does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
TICEBA GmbH Europe
Lophius Biosciences GmbH Europe
Across Barriers GmbH Europe
Mediport Biotechnik GmbH Europe
CANDOR Bioscience GmbH Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EleGene AG, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.